An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound Infections

Bacterial infections occur when wound healing fails to reach the final stage of healing, which is usually hindered by the presence of different pathogens. Different topical antimicrobial agents are used to inhibit bacterial growth due to antibiotic failure in reaching the infected site, which is acc...

Full description

Bibliographic Details
Main Authors: Viorica Patrulea, Gerrit Borchard, Olivier Jordan
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/12/9/840
_version_ 1827707010346385408
author Viorica Patrulea
Gerrit Borchard
Olivier Jordan
author_facet Viorica Patrulea
Gerrit Borchard
Olivier Jordan
author_sort Viorica Patrulea
collection DOAJ
description Bacterial infections occur when wound healing fails to reach the final stage of healing, which is usually hindered by the presence of different pathogens. Different topical antimicrobial agents are used to inhibit bacterial growth due to antibiotic failure in reaching the infected site, which is accompanied very often by increased drug resistance and other side effects. In this review, we focus on antimicrobial peptides (AMPs), especially those with a high potential of efficacy against multidrug-resistant and biofilm-forming bacteria and fungi present in wound infections. Currently, different AMPs undergo preclinical and clinical phase to combat infection-related diseases. AMP dendrimers (AMPDs) have been mentioned as potent microbial agents. Various AMP delivery strategies that are used to combat infection and modulate the healing rate—such as polymers, scaffolds, films and wound dressings, and organic and inorganic nanoparticles—have been discussed as well. New technologies such as Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated protein (CRISPR-Cas) are taken into consideration as potential future tools for AMP delivery in skin therapy.
first_indexed 2024-03-10T16:37:37Z
format Article
id doaj.art-369cad3550bf4e6e93de04bd4ea512bc
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T16:37:37Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-369cad3550bf4e6e93de04bd4ea512bc2023-11-20T12:17:58ZengMDPI AGPharmaceutics1999-49232020-09-0112984010.3390/pharmaceutics12090840An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound InfectionsViorica Patrulea0Gerrit Borchard1Olivier Jordan2Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1 Rue Michel Servet, 1211 Geneva, SwitzerlandInstitute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1 Rue Michel Servet, 1211 Geneva, SwitzerlandInstitute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1 Rue Michel Servet, 1211 Geneva, SwitzerlandBacterial infections occur when wound healing fails to reach the final stage of healing, which is usually hindered by the presence of different pathogens. Different topical antimicrobial agents are used to inhibit bacterial growth due to antibiotic failure in reaching the infected site, which is accompanied very often by increased drug resistance and other side effects. In this review, we focus on antimicrobial peptides (AMPs), especially those with a high potential of efficacy against multidrug-resistant and biofilm-forming bacteria and fungi present in wound infections. Currently, different AMPs undergo preclinical and clinical phase to combat infection-related diseases. AMP dendrimers (AMPDs) have been mentioned as potent microbial agents. Various AMP delivery strategies that are used to combat infection and modulate the healing rate—such as polymers, scaffolds, films and wound dressings, and organic and inorganic nanoparticles—have been discussed as well. New technologies such as Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated protein (CRISPR-Cas) are taken into consideration as potential future tools for AMP delivery in skin therapy.https://www.mdpi.com/1999-4923/12/9/840bacterial infectionnon-healing woundsantimicrobial resistancemultidrug resistanceantimicrobial peptides (AMPs)AMP conjugates
spellingShingle Viorica Patrulea
Gerrit Borchard
Olivier Jordan
An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound Infections
Pharmaceutics
bacterial infection
non-healing wounds
antimicrobial resistance
multidrug resistance
antimicrobial peptides (AMPs)
AMP conjugates
title An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound Infections
title_full An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound Infections
title_fullStr An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound Infections
title_full_unstemmed An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound Infections
title_short An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound Infections
title_sort update on antimicrobial peptides amps and their delivery strategies for wound infections
topic bacterial infection
non-healing wounds
antimicrobial resistance
multidrug resistance
antimicrobial peptides (AMPs)
AMP conjugates
url https://www.mdpi.com/1999-4923/12/9/840
work_keys_str_mv AT vioricapatrulea anupdateonantimicrobialpeptidesampsandtheirdeliverystrategiesforwoundinfections
AT gerritborchard anupdateonantimicrobialpeptidesampsandtheirdeliverystrategiesforwoundinfections
AT olivierjordan anupdateonantimicrobialpeptidesampsandtheirdeliverystrategiesforwoundinfections
AT vioricapatrulea updateonantimicrobialpeptidesampsandtheirdeliverystrategiesforwoundinfections
AT gerritborchard updateonantimicrobialpeptidesampsandtheirdeliverystrategiesforwoundinfections
AT olivierjordan updateonantimicrobialpeptidesampsandtheirdeliverystrategiesforwoundinfections